The CERES scores of other genes, such as RAF1, ABCB11, LIG3, and IARS, were less than 0 in most AML cell lines, suggesting that AML patients with poorer prognosis may benefit from treatment targeting these genes. The gene discussed is IARS1; the disease is acute myeloid leukemia.